Pre-earnings brief
Reports
Mon, Nov 2, 2026
Est. EPS
$0.09
Est. revenue
$27M
Implied move
±18.8%
EPS beat rate
100%
Aehr Test Systems, Inc. specializes in semiconductor testing equipment, which is crucial for ensuring the reliability and performance of chips used in various technologies. As the demand for semiconductors continues to grow, particularly in areas like AI and cloud computing, Aehr's role in this sector becomes increasingly significant.
Last quarter
In the last quarter, Aehr reported an EPS of $0.11, significantly beating expectations of a loss. The stock reacted positively, gaining 5.87% the following day.
Management promises and guidance
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+246.58%
Avg 1-day reaction
-0.92%
Analysts are cautiously optimistic about Aehr's upcoming earnings, expecting a modest profit and steady revenue growth. The company has a strong track record of beating earnings estimates.
Bull case
If Aehr exceeds the consensus EPS and revenue estimates, it could signal strong demand for its semiconductor testing solutions, leading to a positive stock reaction.
Bear case
Conversely, if the company fails to meet expectations or provides weak guidance, it could raise concerns about market demand and impact the stock negatively.
Key metrics to watch
EPS
$0.09Earnings per share is a key indicator of the company's profitability and financial health.
Revenue
$27MRevenue figures provide insight into the company's sales performance and market demand for its products.
The print will turn on these.
Q1
Will Aehr achieve an EPS of $0.09 or better?
This figure is critical as it reflects the company's profitability and could influence investor confidence.
Q2
What will the revenue figure be relative to the $27M consensus?
Revenue performance is a key indicator of market demand and operational efficiency, which can affect future growth prospects.
—
Est. EPS
$-0.50
Est. Rev
$257M
Impl. Move
±7.5%
Why consensus could be wrong
The market may be underestimating Aehr's potential for higher-than-expected revenue growth due to increasing demand for semiconductor testing solutions, particularly in AI applications.
Supporting evidence
The company's recent track record of beating EPS estimates suggests stronger operational performance than anticipated.
Options pricing indicates a significant move, reflecting uncertainty that could favor a positive surprise.
Historical performance shows that Aehr has consistently surprised on the upside, which may not be fully factored into current estimates.
Key risk
If the revenue comes in below $25M, it could undermine confidence in the company's growth trajectory.
Pre-commit to what would confirm each case.
This quarter's performance is pivotal as it will provide insights into Aehr's ability to capitalize on the growing semiconductor market.
Bull confirmed if
Achieving an EPS of $0.10 or higher with revenue exceeding $28M would confirm strong demand and operational success.
Bear confirmed if
An EPS below $0.07 or revenue falling short of $25M would signal potential issues in demand or execution.
What the market is pricing for the move.
Implied Move
±34.7%
Historical Avg
±3.7%
The options market is pricing in a significant potential move in either direction, indicating uncertainty around the earnings report.
Options are pricing ±18.8% while AEHR has averaged ±3.7% over the last 8 prints — setup is pricing rich.
ATM IV
1.1%
30d HV
92.0%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Semiconductors
Fade rate: 13 of 29 (45%)
This setup has occurred 30 times across Information Technology in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 4.8%, with a raw directional average of -2.3% (modestly negative historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
76.04%
of float
Insider
3.30%
of float
Holders
361
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
2,659,542 sh · $237.7M
8.14%
16.3%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Aehr beats expectations, history suggests the stock could see a positive reaction, potentially around a 3% increase.
In line / cautious
If results are in line with expectations but management is cautious, the stock may experience muted movement as investors reassess future growth.
Miss
Should the company miss estimates, historical patterns indicate a potential decline of around 3% or more.
The lines on the call that would change the story.
Vanguard Capital Management LLC
1,320,350 sh · $118.0M
4.04%
3.0%
Shaw D.E. & Co., Inc.
1,177,421 sh · $105.2M
3.61%
244.6%
Two Sigma Investments, LP
1,164,614 sh · $104.1M
3.57%
443.3%
FMR, LLC
1,006,830 sh · $90.0M
3.08%
-53.0%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.